Vaccines

Rabies Vaccine

RCR is looking for flexible, healthy, young adults ages 18-40 for a Rabies vaccine trial. The purpose of this study is to determine the safety and effectiveness of a new vaccine. Compensation is available for time and travel.

*Compensation for time and travel may be available to those who qualify.

Coronavirus Vaccine Research Studies

Rochester Clinical Research has several coronavirus vaccine studies starting in 2020, and we will need the help of our community of volunteers.

Coronavirus Update

Rochester Clinical Research is following the ever-changing impact of the Coronavirus on a national level and in our local community. Please review our COVID Reopening Patient Access.

Men’s HPV Vaccine

The purpose of this research study is to determine the efficacy and safety of a 3-dose HPV vaccine in males between the ages of 20- 45. The vaccine aims to prevent HPV infection which are associated with oral cancer.

*Compensation for time and travel may be available to those who qualify.

E. Coli Vaccine

Rochester Clinical Research is currently enrolling individuals over the age of 60 years old, who have had a UTI within the past 5 years, for an E. coli vaccine research study. The study will evaluate the effectiveness of a study vaccine that may protect against E. coli that could cause sepsis.

*Compensation for time and travel may be available to those who qualify.

Chikungunya Vaccine

Rochester Clinical Research is participating in a study evaluating the immune response of a single dose of the study Chikungunya vaccine in healthy adults over the age of 18 years old.

*Compensation for time and travel may be available to those who qualify.